Hematological Oncology

Wiley·United Kingdom·ISSN 0278-0232

Subscription or hybridMedicine

Cost to publish

$4,650

Open-access article processing charge, list price.

Time to publication

—

Not reported to DOAJ.

h-index

OpenAlex citation statistic. Not a Journal Impact Factor.

2-year mean citedness

0.6

Average citations to articles from the previous two years.

What it costs to publish here

Publishing an open-access article in Hematological Oncology is listed at $4,650. The publisher also lists 3,920 EUR, 3,120 GBP. No waiver policy is recorded in our sources, which does not mean none exists. Ask.

What this journal has charged over time

List price for an open-access article in Hematological Oncology, as recorded by OpenAlex for each year. The fee has risen 33% since 2019, from $3,500 to $4,650.

Publishers change list prices without notice and often apply discounts, institutional agreements or waivers. Treat this as the trend, and confirm the current figure with the journal.

Peer review and licensing

Review model	Not reported
Licence	Not reported
Author keeps copyright	Not reported
Plagiarism screening	Not reported
Editorial board	Not linked in DOAJ
Languages	Not reported

Verification checks

3 of 8 confirmed

These are facts we could verify in public records, not a verdict. A journal missing a check is not necessarily disreputable — many long-established subscription journals sit outside the open-access registries entirely. Use them as questions to ask, and confirm anything that matters directly with the journal before you submit.

Listed in the Directory of Open Access JournalsNot listed. Many legitimate subscription journals are not in DOAJ, so this alone means little.Not confirmed
Included in OpenAlex's curated core setOpenAlex flags well-established venues that appear across major indexes.Confirmed
Peer review model publicly declaredNo declared model found in DOAJ.Not confirmed
Publication charges stated up frontA journal that will not tell you the fee before submission is worth a second look.Confirmed
Screens submissions for plagiarismReported to DOAJ by the journal.Not confirmed
Participates in a digital preservation schemeArchiving means the record survives if the publisher does not.Not confirmed
Assigns persistent identifiers (DOIs)Standard practice; its absence is unusual.Not confirmed
Still actively publishingMost recent indexed article: 2026.Confirmed

Scope

The subjects Hematological Oncology publishes most, derived from the topics assigned to its indexed articles.

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchCAR-T cell therapy researchCNS Lymphoma Diagnosis and TreatmentViral-associated cancers and disordersAcute Myeloid Leukemia ResearchAcute Lymphoblastic Leukemia researchLung Cancer Treatments and MutationsMultiple Myeloma Research and TreatmentsChronic Myeloid Leukemia Treatments

Publication record

Indexed articles	6,028
Total citations	41,888
i10-index	1,153
Most recent indexed article	2026
All ISSNs	0278-0232, 1099-1069

Counts reflect what OpenAlex has indexed and will differ from the publisher's own figures. We do not show a founding year: OpenAlex's first-publication dates are distorted by mis-dated records — it puts PLoS ONE in 1806 — and we would rather omit a number than print one we cannot stand behind.